Melissa Dodds, MD
Dermatology · Dubuque, IANPI 1023512191
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $517 of the $813 with a category attached, or 63.6%. 9 manufacturers reported payments, led by Johnson & Johnson at 30.7% of the total. Reporting peaked in 2022 at $263 and has fallen 93.4% since, to $17 in 2025. That places this record below the midpoint for dermatology clinicians in IA, where the typical reported total is $716.
Across 13 payments — averaging $62.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$250
- Merz North America, Inc.$163
- AbbVie$108
- Boehringer Ingelheim$108
- Lilly USA, LLC$72
- Pfizer$46
- plus $66 from 3 others
What the payments were for
- Food & beverage$51764%
- Education$29636%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 3 | $250 |
| Merz North America, Inc. | 1 | $163 |
| AbbVie | 1 | $108 |
| Boehringer Ingelheim | 1 | $108 |
| Lilly USA, LLC | 1 | $72 |
| Pfizer | 3 | $46 |
| Incyte Corporation | 1 | $25 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $23 |
| Conmed Corporation | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$813 in reported general payments places this provider in the 50th percentile of 92 dermatology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 54 | $4,810 |
| Fluorouracil | 23 | $1,815 |
| Ketoconazole | 100 | $1,570 |
| Fluocinonide | 20 | $1,378 |
| Triamcinolone Acetonide | 158 | $1,060 |
| Mycophenolate Mofetil | 21 | $897 |
| Metronidazole | 15 | $746 |
| Doxycycline Hyclate | 32 | $701 |
| Betamethasone Valerate | 14 | $558 |
| Clindamycin Phosphate | 15 | $447 |
| Pentoxifylline | 14 | $272 |
| Imiquimod | 11 | $224 |
| Finasteride | 42 | $208 |
| Hydrocortisone | 47 | $172 |
| Mupirocin | 23 | $167 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Dubuque
- Jennifer SchopeDubuque$1K
- Emily WeigDubuque$1K
- Roger CeilleyWest Des Moines$82K
- David KnutsonCedar Rapids$60K
- Scott GreenFort Dodge$56K
- Timothy AbrahamsonUrbandale$49K
- Ali JabbariIowa City$38K
- Ravindrakumar GangadhariahDavenport$20K
- Somaira NowsheenWaukee$15K
- Laura MyersAnkeny$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.